Rebuilding the Lacrimal Blueprint
Autophagy: an unexpected gatekeeper of lacrimal gland development
Clinical Scorecard: Rebuilding the Lacrimal Blueprint
At a Glance
Category Detail
Condition Dry Eye Disease (DED) Key Mechanisms Autophagy's role in lacrimal gland development and function Target Population Individuals with Dry Eye Disease Care Setting Clinical and research settings focusing on ocular health
Key Highlights
Autophagy is essential for lacrimal gland differentiation and function. Genetic disruption of autophagy leads to structural and functional abnormalities in lacrimal gland organoids. Nicotinamide mononucleotide (NMN) and melatonin show potential to restore function in autophagy-deficient organoids. NMN reverses deeper cellular abnormalities linked to chronic DED. Study provides insights into maintaining and restoring lacrimal gland health. Guideline-Based Recommendations
Diagnosis
Assess lacrimal gland function and structure in patients with DED. Management
Consider pharmacological agents like NMN and melatonin for potential therapeutic effects. Monitoring & Follow-up
Monitor secretion levels and cellular health markers in patients undergoing treatment. Risks
Be aware of potential cellular stress and degeneration in autophagy-deficient conditions. Patient & Prescribing Data
Patients with chronic Dry Eye Disease and lacrimal gland dysfunction.
NMN may offer a novel approach to restore lacrimal gland function by normalizing NAD⁺ metabolism.
Clinical Best Practices
Incorporate autophagy assessment in the evaluation of lacrimal gland health. Explore the use of NMN and melatonin in clinical trials for DED management. References
